Skip to main content

Xtant Medical Holdings, Inc. (XTNT)

NYSEAMERICAN: XTNT · IEX Real-Time Price · USD
0.782 -0.027 (-3.31%)
Nov 26, 2021 1:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year2020201920182017201620152014201320122011
Revenue
53.3464.6872.282.619059.3535.3333.0732.9830.15
Revenue Growth
-17.54%-10.42%-12.60%-8.21%51.66%67.97%6.83%0.28%9.39%-
Cost of Revenue
18.9522.1728.7232.5127.7120.2613.0314.1910.349.11
Gross Profit
34.3942.5243.4950.162.2939.0822.318.8922.6421.04
Selling, General & Admin
34.4943.8445.7455.7659.8241.7225.826.2226.7525.44
Research & Development
0.660.931.72.443.412.551.440.5700
Other Operating Expenses
0056.1229.746.619.241.321.10.832.05
Operating Expenses
35.1444.77103.5687.9469.8453.5128.5627.927.5927.49
Operating Income
-0.75-2.25-60.08-37.83-7.55-14.42-6.26-9.01-4.94-6.45
Interest Expense / Income
5.985.7710.1514.7112.267.735.664.651.861.16
Other Expense / Income
00.1-0.12-0.13-0.36-2.45-1.42-0.970.9-4.61
Pretax Income
-6.73-8.12-70.1-52.41-19.44-19.71-10.51-12.69-7.71-3.01
Income Tax
0.30.1000.05-17.540000
Net Income
-7.02-8.22-70.1-52.41-19.49-2.17-10.51-12.69-7.71-3.01
Net Income Common
-7.02-8.22-70.1-52.41-19.49-2.17-10.51-12.69-7.71-3.01
Shares Outstanding (Basic)
2813122110000
Shares Outstanding (Diluted)
2813122110000
Shares Change
116.50%12.12%678.67%42.79%39.93%52.09%31.44%6.73%8.99%-
EPS (Basic)
-0.25-0.63-5.97-34.76-18.46-2.88-21.12-33.60-21.60-9.60
EPS (Diluted)
-0.25-0.63-5.97-34.76-18.46-2.88-21.12-33.60-21.60-9.60
Free Cash Flow Per Share
-0.07-0.070.07-1.43-19.15-12.85-15.36-14.80-35.70-26.07
Gross Margin
64.48%65.73%60.23%60.65%69.21%65.86%63.11%57.11%68.66%69.79%
Operating Margin
-1.41%-3.48%-83.21%-45.80%-8.38%-24.30%-17.73%-27.24%-14.99%-21.39%
Profit Margin
-13.17%-12.71%-97.09%-63.44%-21.66%-3.66%-29.74%-38.38%-23.39%-9.97%
Free Cash Flow Margin
-3.82%-1.48%1.17%-2.60%-22.47%-16.34%-21.57%-16.89%-38.29%-28.07%
Effective Tax Rate
-4.40%-1.21%0.00%0.00%-0.26%88.97%0.00%0.00%0.00%0.00%
EBITDA
1.330.79-53.36-29.30.06-7.09-3.9-7.29-5.07-1.09
EBITDA Margin
2.49%1.22%-73.91%-35.46%0.07%-11.94%-11.02%-22.03%-15.36%-3.61%
EBIT
-0.75-2.35-59.95-37.71-7.18-11.98-4.85-8.04-5.85-1.84
EBIT Margin
-1.41%-3.63%-83.04%-45.64%-7.98%-20.18%-13.72%-24.31%-17.73%-6.12%
Showing 10 of 13 years
3 more years are available
Start Free Trial
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).